Melanoma Institute Australia

Wollstonecraft, New South Wales 2065

5 studies enrolling now · 8 studies all time

What they study most

Advanced Malignancies, Advanced Melanoma, Advanced Solid Tumor, Advanced Solid Tumors, Cutaneous Melanoma, Stage III, Melanoma, Metastatic Uveal Melanoma, NSCLC, Non-small Cell Lung Cancer, Ovarian Cancer, Solid Tumor, Adult, Solid Tumors

Studies at this site

• A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors — Recruiting now
• Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors — Recruiting now
• The Multicentre Selective Lymphadenectomy Trial - 3 — Recruiting now
• A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma — Recruiting now
• Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) — Recruiting now
• Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing — Running, not enrolling
• A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors — Running, not enrolling
• Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies — Completed